🇺🇸 FDA
Pipeline program

Tigulixostat

LG-GDCL009

Phase 3 small_molecule completed

Quick answer

Tigulixostat for Gout is a Phase 3 program (small_molecule) at LG Chem with 2 ClinicalTrials.gov record(s).

Program details

Company
LG Chem
Indication
Gout
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials